SlideShare ist ein Scribd-Unternehmen logo
1 von 58
MIGRAINE




-   Dr. Raajit Chanana
         1
Introduction


∗ Migraine headache is a complex recurrent headache that
  is one of the most common complaints in medicine.




                           2
Classification of Migraine




            3
Migraine with Aura




        4
Childhood periodic syndromes that are
  commonly precursors of migraine




                 5
Complications of migraine




           6
Probable Migraine




       7
Pathophysiology
                         Vascular theory

It   was believed that ischemia induced by intracranial
   vasoconstriction is responsible for the aura of migraine and the
   subsequent rebound vasodilation and activation of perivascular
   nociceptive nerve resulted in headache.
Based on 3 observations -:
1. Extracranial vessels become distended and pulsatile during an
   attack
2. Stimulation of an intracranial vessels in an awake person induces
   headache
3. Vasoconstrictors improve the headache and vaso dilators provoke
   an attack                        8
Patho Physiology contd…

  Neurovascular theory
∗ Complex series of neural and vascular events initiates migraine
∗ Migraine is primarily a neurogenic process with secondary
  changes in cerebral perfusion


  Cortical spreading depression
∗ CSD is a well defined wave of neuronal excitation in the cortical
  grey matter that spreads from its site of origin at the rate of 2-
  6mm/min
∗ This cellular depolarization causes the primary cortical
  phenomenon aura phase, in turn, it activates trigeminal fibers
  causing headache.             9
Patho Physiology contd…

  Vasoactive substances and Neurotransmitters
∗ Perivascular nerve activity results in release of substances
  such as substance P, neurokinin A, CGRP and NO which
  produce vessel dilation, protein extravasation and sterile
  inflammation stimulating the trigeminocervical complex.


  Cutaneous Allodynia
∗ Secondary pain pathways of the trigeminophthalamic system
  become sensitized during a migraine attack.
                                10
Patho Physiology contd…
   Dopamine pathway
∗ Some of the symptoms associated with migraine such as nausea,
  vomiting, yawning, hyperactivitycan be attributed to
  dopaminergic stimulation.
  Endothelial dysfunction
  Serotonin and migraine
∗ Plasma extravasation mediated by vasoactive substances is
  blocked by ergots, sumatriptan, indomethacin, GABA agonists
  and benzodiazepines
∗ 5HT-1D receptors in trigeminal sensory neurons and 5HT 1B
  receptors are present on smooth vessels in the meningeal
  vessels                        11
Etiology

∗ Approx 70% of patients have a first degree relative with a history
  of migraine.
  Familial Hemiplegic Migraine
∗ Migraine with aura that is preceded or followed by hemiplegia
  that typically resolves
∗ FHM type 1 - Linked to mutations in the calcium channel gene –
  chromosome 19.May be associated with cerebellar ataxia
∗ FHM type 2 - mutation in the sodium channel gene ATP1A2 on
  chromosome 3
∗ FHM type 3- mutation in a sodium channel alpha subunit coding
  gene
                                  12
Etiology contd…


  Migraine in inherited disorders -:

1. MELAS (mitochondrial myopathy, encephalopathy and lactic
   acidosis)
2. CADASIL (cerebral autosomal dominant arteriopathy with
   subcortical infarcts and leukoencephalopathy)
3. Genetic vasculopathies like RVCL (retinal vasculopathy with
   cerebral leukodystrophy) etc.


                                  13
Epidemiology


∗ Migraine accounts for 64% of severe headaches in females and
  43% of severe headaches in males.
         Migrain Without Aura              Migraine with Aura
         Boys            Girls              Boys         Girls
    Peaks at 5 years  12-13 years        10-11 years 14-17 years


∗ In individuals >12yr of incidence increases with age, reaching a
  peak at 30-40 yrs
∗ F:M = 3.5:1 at 40yrs
                                  14
Clinical presentation

  History
∗ U/L, throbbing or pulsatile localized in the frontotemporal and
  ocular areas but be felt anywhere around the head or neck.
∗ Pain builds over 1-2 hrs and become diffuse.
∗ Many patient prefer to lie in dark room

  Other symptoms
∗ Nausea, vomiting, anorexia and food intolerance occur in about
  50 % of patients. Photophobia and phonophobia are commonly
  associated with headache.
∗ Hemiparesis, confusion, apathy 15 numbness.
                                  and
Clinical presentation contd…

    Prodrome
∗   About 60% of patients report premonitory symptoms that occur
    hours to days before headache onset.
∗   Heightened sensitivity to light, sounds and odors.
∗   Lethargy or uncontrollable yawning.
∗   Food cravings
∗   Mental and mood changes
∗   Excessive thirst and polyuria
∗   Anorexia
∗   Constipation or diarrhea
                                16
Aura

∗ It is a complex of neurologic symptoms that may precede or
  accompany the headache phase or may occur in isolation.
∗ Usually develops over 5-20min and lasts less than 60 minutes.
∗ Can be visual, sensory, motor or combination of these

  Negative symptoms -:
∗ Negative scotoma
∗ Negative visual phenomenon such as homonymous hemianopia,
  central scotoma, tunnel vision, altitudinal visual defects etc.


                                 17
Aura contd…

    Positive symptoms
∗   Scintillating scotoma-highly characteristic of migraine
∗   Photopsia or flashes of light
∗   Heat waves
∗   Micropsia, macropsia

  Paresthesia
  Occurring in 40%of cases constitute the next most common aura.
∗ Sensory symptoms rarely occurs in isolation and usually follows visual
  aura.
∗ Motor symptoms may occur in 18% of patients
∗ Speech and language disturbances have been reported in 17-20% of
  patients                          18
Scintillating Scotoma




          19
Central Scotoma




       20
Multiple spotty scotoma




           21
Half visual field loss




          22
Migraine triggers
∗   Stress
∗   Excessive or insufficient sleep
∗   Medications (OCP, vasodilators)
∗   Strong odors eg. perfumes, cologne etc.
∗   Hormonal changes such as pregnancy, menstruation
∗   Head trauma
∗   Weather changes
∗   Metabolic or infectious disease
∗   Physical exertion
∗   Cold stimulus eg. ice cream
                                 23
Migraine triggers contd…


∗ Foods containing tyramine may provoke migraine
1. Aged cheese
2. Yogurt
3. Bananas
4. Vinegar
5. Beans
6. Peanuts


                          24
∗ Family history
∗ Approx 70% of patients have a first-degree relative with a
  history of migraine

∗ Disability assessment
∗ Simple questionnaires like MIDAS migraine disability
  assessment can be used to quantify the disability and for
  follow up
                               25
Physical Examination

∗ Thorough neurologic examination is essential, results will be
  normal in majority
∗ Possible findings may include
∗ Cranial/cervical muscle tenderness
∗ Horner syndrome
∗ Tachycardia/ bradycardia
∗ Conjunctival injection
∗ Hypertension/hypotension
∗ Hemisensory/ hemiparetic neurological deficits
  ( complicated migraine)      26
Physical Examination contd…


∗ Findings that suggest a headache diagnosis other than
  migraine
∗ Dim scotoma lasting a few seconds to several minutes ie
  amaurosis
∗ Temporal artery tenderness
∗ Meningisnus
∗ Mental status changes
∗ Focal neurologic deficit eg confusion, seizures

                             27
Physical Examination contd…


∗ Focal neurologic findings that occur with headache and
  persist temporarily after the pain resolves suggests a
  migraine variant
∗ U/L paralysis or weakness-hemiplegic migraine
∗ Aphasia, dysarthria, vertigo, tinnitus, syncope, balance
  problems-basilar migraine
∗ Third nerve palsy with sparing of pupillary response-
  ophthalmoplegic migraine

                            28
Diagnostic criteria
∗ Migraine without aura
 Diagnostic criteria:
 A. At least 5 attacks fulfilling criteria B-D
 B. Headache attacks lasting 4-72 hours (untreated or
  unsuccessfully treated)
 C. Headache has at least two of the following characteristics:
  1. unilateral location
  2. pulsating quality
  3. moderate or severe pain intensity
  4. aggravation by or causing avoidance of routine physical
  activity (eg. walking or climbing stairs)
                                  29
Diagnostic criteria contd…

∗ D. During headache at least one of the following:
   1. nausea and/or vomiting
   2. photophobia and phonophobia

∗ E. Not attributed to another disorder




                                30
Migraine with aura


Diagnostic criteria -:
A. At least 2 attacks fulfilling criterion B

B. Migraine aura fulfilling criteria B and C for one of the
  subforms 1.2.1-1.2.6 as per the IHS classification

C. Not attributed to another disorder



                                 31
Typical aura
                 with migraine headache

A. At least 2 attacks fulfilling criteria B–D

B. Aura consisting of ≥1 of the following, but no motor weakness:
   1. fully reversible visual symptoms including positive and/or
      negative features
   2. fully reversible sensory symptoms including positive and/or
      negative features
   3. fully reversible dysphasic speech disturbance


                                     32
Typical aura
          with migraine headache contd…
C. At least two of the following:
    1. homonymous visual symptoms and/or unilateral sensory
        symptoms
    2. at least one aura symptom develops gradually over ≥5 min
        and/or different aura symptoms occur in succession over ≥5
        min
    3. each symptom lasts ≥5 and ≤60 min
D. Headache fulfilling criteria B-D for 1.1 Migraine without aura
  begins during the aura or follows aura within 60 min
E. Not attributed to another disorder
                                 33
Complications of migraine

∗ Chronic migraine
  Migraine headache that occurs more than 15 days a month for
     greater than 3 months
∗ Status migrainosus
  Migraine attacks persists for >72 hours.
∗ Persistent aura ( 30-60 min ) without infarction
∗ Migrainous infarction
∗ Migraine triggered seizures



                               34
Work up


∗   Migraine is a clinical diagnosis.
∗    Diagnostic investigations are performed due to following reasons
∗   Exclude structural, metabolic and causes of heada
∗   Rule out comorbid disease that could complicate headache and
    its treatment




                                  35
∗ Neuroimaging is usually not necessary except
∗ Onset of migraine after 5o years of age
∗ change in the pattern of previous migraine
∗ First or worst severe headache
∗ New onset of headache in a patient with cancer or HIV patient
∗ Headache with an abnormal neurologic examination
∗ Headache with fever
∗ Migraine and epilepsy
∗ New daily persistent headache
∗ Escalation of headache frequency/intensity in the absence of
  medication overuse headache
∗ Posteriorly located headaches in children
                               36
∗ Visual field testing should be performed in patients with
  persistent visual phenomenon

∗ Indications for lumber puncture include -:
1. First or worst headache of a patients life
2. Severe, rapid onset, recurrent headaches
3. Progressive headaches
4. Atypical chronic intractable headaches




                                  37
Management


∗ Acute attack
∗ Preventive




                     38
General principles of management


∗ Establish a diagnosis.
∗ Educate migraine sufferers about their condition and its
  treatment.
∗ Encouraging patients to track their own progress through the use
  of diary cards, flow charts, headache calendars and frequency
  and severity of attacks, the presence and degree of temporary
  disability, and associated symptoms such as nausea and vomiting.
∗ Create a formal management plan and individualize
  management. Consider comorbidity/coexisting conditions (such
  as heart disease, pregnancy, and uncontrolled hypertension).
                                 39
General principles of management contd..


∗ Encourage the patient to identify and avoid triggers.
∗ Guard against medication-overuse headache (“rebound
  headache” or “drug-induced headache”). Frequent use of acute
  medications (ergotamine [not DHE], opiates, triptans, simple
  analgesics, and mixed analgesics) is generally thought to cause
  medication-overuse headache.
∗ Use migraine-specific agents (triptans dihydroergotamine [DHE])
  in patients with moderate or severe migraine or whose mild-to-
  moderate headaches respond poorly to nonsteroidal anti-
  inflammatory drugs (NSAIDs) or combinations such as aspirin plus
  acetaminophen plus caffeine

                                40
Acute Treatment

Goals of acute migraine treatment are as follows:
∗ Treat attacks rapidly and consistently without recurrence.
∗ Restore the patient’s ability to function.
∗ Minimize the use of back-up and rescue medications. (A rescue
  medication is used at home when other treatments fail and
  permits the patient to achieve relief without the discomfort and
  expense of a visit to the physician’s office or emergency
  department.)
∗ Be cost-effective for overall management.
∗ Have minimal or no adverse events
                                41
Specific medications

Triptan (serotonin 1B/1Dreceptor agonists)
∗ Effective and safe
∗ acute management
∗ Appropriate initial choice in patients with moderate to severe
  migraine
∗ Routes-oral, subcutaneous and nasal
∗ Drugs – sumatriptan-50-100mg tablet at onset , may repeat after
  2hour (max 200mg/d)
∗ Rizatriptan –most efficacious, early onset of action, 5-10 mg
  tablet at onset may repeat after 2hr max 30mg/d)
∗ Naratriptan, almotriptan,frovatriptan, zolmitriptan
                                 42
Specific medications contd…


∗ Triptans should not be used more than 3 days weekly to avoid
  transformed migraine and medication overuse headache
∗ Caution-avoid in patients of CAD
∗ Adverse effects
∗ Paresthesia, jaw or neck tightness, warm/cold sensation etc.




                                43
Specific medications contd…

∗ Ergot alkaloids and derivatives-nonselective 5-HT1 agonists)
∗ Ergotamine PO/PR (and caffeine combination) may be considered
  in the treatment of selected patients with moderate to severe
  migraine.
∗ Dose 2mg PO, f/b 1-2mg every 30 min until attack is aborted, no
  more than 6mg/day
∗ Adverse effects-vasospasm, angina, tachycardia, numbness of
  extremities, rebound headache, ergotism, gangrene etc


                                44
Specific medications contd…

∗ Dihydroergotamine- alpha adrenergic blocking agent with a
  direct stimulating effect on smooth muscle of peripheral and
  cranial blood vessels. It is a non selective 5-HT1 agonist
∗ Route- iv or nasal
∗ Dose- 1mg iv/im repeated 1 hrly , no more than 3 mg for im and
  2mg for iv
∗ Nasal-1 spray 0.5mg in each nostril not more than 6 sprays/24hr
∗ DHE nasal spray is safe and effective for the treatment of acute
  migraine attacks and should be considered for use in patients with
  moderate to severe migraine
∗ DHE IV plus antiemetics IV is an appropriate treatment choice for
  patients with severe migraine

                                 45
Non specific medications
  Antiemetics -:
∗Oral antiemetics are an adjunct to treat nausea associated with
migraine .
∗Metoclopramide IM/IV is an adjunct to control nausea and may be
considered as IV monotherapy for migraine pain relief
∗Prochlorperazine IV, IM, and PR may be a therapeutic choice for
migraine in the appropriate setting
∗Chlorpromazine IV
∗ Serotonin receptor (5-HT3) antagonists may be considered as
adjunct therapy to control nausea in selected patients with migraine
attacks

                                 46
Non specific medications contd…


∗ NSAIDs, nonopiate analgesics, and combination analgesics.
∗ Acetaminophen, alone, is not recommended for migraine .
∗ NSAIDs (oral) and combination analgesics containing caffeine are
  a reasonable first-line treatment choice for mild to moderate
  migraine attacks or severe attacks that have been responsive in
  the past to similar NSAIDs or nonopiate analgesics




                                47
Non specific medications contd…
∗ Opiate analgesics.
∗ Butorphanol nasal spray is a treatment option for some patients
  with migraine (Grade A). Butorphanol may be considered when
  other medications cannot be used or as a rescue medication when
  significant sedation would not jeopardize the patient
∗ Other medications.
∗ Isometheptene and isometheptene combination agents may be a
  reasonable choice for patients with mild-to-moderate headache .
∗ Corticosteroids (dexamethasone or hydrocortisone) are a
  treatment choice for rescue therapy for patients with status
   migrainosus .

                                48
Preventive treatment


    May be considered when -:
∗   Frequency of migraine is >2/months
∗   Duration of individual attack is longer than 24hrs
∗   Headache causes major disruption in patients lifestyle
∗   Abortive therapy fails or is overused
∗   Symptomatic medications are ineffective
∗   Use of abortive medications more than twice a week
∗   Migraine variants such as hemiplegic migraine

                                   49
∗ The goals of migraine preventive therapy are to
1) reduce attack frequency, severity, and duration
2)improve responsiveness to treatment of acute attacks
3)improve function and reduce disability




                               50
Pharmacotherapy

    5 principal classes of drugs are used -:
∗   Antiepileptics
∗   Antidepressants
∗   Antihypertenseives
∗   Serotonin antagonists
∗   NSAIDS




                                     51
ANTIEPILEPTICS

∗   Well tolerated
∗   Valproic acid is useful as afirst line agent.400-600 mg BD
∗   Carbamazepine
∗   Gabapentin
∗   topiramate




                                    52
∗ ANTIDEPRESSANTS


∗ Tricyclic antidepressants
∗ Amitriptyline- 10-75mg at night
∗ Nortriptyline


  Selective serotonin reuptake inhibitors
∗ Fluoxetine

∗ Other antidepressants
∗ Bupropion, mirtazepine, trazodone, venlafaxine

                                    53
∗ ANTIHYPERTENSIVES


∗ Beta-blockers
∗ Propranolol -40-120mg BD
∗ Timolol


∗   Calcium channel blockers
∗   Diltiazem
∗   Nimodipine
∗   Verapamil


                               54
SEROTONIN ANTAGONISTS
    Methysergide-1-4mg OD
∗ Flunarizine5-15mg OD

∗   NSAIDS
∗   Aspirin
∗   Mefenamic acid
∗   Ibuprofen
∗   Naproxen/naproxen sodium

∗ Other
∗ Magnesium
∗ Vitamin B2

                               55
∗ Special considerations
∗ Direct special attention to women who are pregnant or want to
  become pregnant. Preventive medications may have teratogenic
  effects.
∗ Take     coexisting      conditions     into     account.    Some
  (comorbid/coexisting) conditions are more common in persons
  with migraine.
∗ Eg-beta blocker are preferred in young anxious patients,
  hypertensive patients, history of angina
∗ TCA’s are preferred in patients of depression, underweight
∗ Valproic acid is preferred in patients of epilepsy and mania


                                 56
Non-pharmacological treatment

∗ Biofeedback
∗ Cognitive-behaviour therapy
∗ Relaxation therapy

∗ AVOIDANCE OF MIGRAINE TRIGGERS

∗   Complimentary and alternative therapy
∗   Body work eg. massage
∗   Creative arts eg. dance, music
∗   Yoga
∗   Acupuncture and acupressure
                                57
Thank You!




    58

Weitere ähnliche Inhalte

Was ist angesagt? (20)

Headaches
Headaches  Headaches
Headaches
 
Headache
HeadacheHeadache
Headache
 
Migraine
MigraineMigraine
Migraine
 
Migraine
MigraineMigraine
Migraine
 
Migraine Basics Presentation by Decontee "Dr. Dee" Jimmeh, MD
Migraine Basics Presentation by Decontee "Dr. Dee" Jimmeh, MDMigraine Basics Presentation by Decontee "Dr. Dee" Jimmeh, MD
Migraine Basics Presentation by Decontee "Dr. Dee" Jimmeh, MD
 
Migraine and types
Migraine and typesMigraine and types
Migraine and types
 
Headache types & management
Headache types & managementHeadache types & management
Headache types & management
 
Management of migrine
Management of migrineManagement of migrine
Management of migrine
 
Approach to a_case_of_headache
Approach to a_case_of_headacheApproach to a_case_of_headache
Approach to a_case_of_headache
 
Migraine
MigraineMigraine
Migraine
 
Tension Type Headache (TTH)
Tension Type Headache (TTH)Tension Type Headache (TTH)
Tension Type Headache (TTH)
 
Headache
HeadacheHeadache
Headache
 
Managament Of Migraine
Managament Of MigraineManagament Of Migraine
Managament Of Migraine
 
Migraine Headache
Migraine HeadacheMigraine Headache
Migraine Headache
 
Headache ppt
Headache pptHeadache ppt
Headache ppt
 
Headaches Lecture
Headaches LectureHeadaches Lecture
Headaches Lecture
 
Headache
HeadacheHeadache
Headache
 
MIGRAINE
MIGRAINEMIGRAINE
MIGRAINE
 
Classification and pathophysiology of headache
Classification and pathophysiology of headacheClassification and pathophysiology of headache
Classification and pathophysiology of headache
 
HEADACHE - CLASSIFICATION
HEADACHE - CLASSIFICATIONHEADACHE - CLASSIFICATION
HEADACHE - CLASSIFICATION
 

Andere mochten auch (10)

Yoga for headache
Yoga for headacheYoga for headache
Yoga for headache
 
Pharmacotherapy of migraine
Pharmacotherapy of migrainePharmacotherapy of migraine
Pharmacotherapy of migraine
 
Headache.ppt
Headache.pptHeadache.ppt
Headache.ppt
 
Plantar fasciitis
Plantar fasciitisPlantar fasciitis
Plantar fasciitis
 
Migraine
MigraineMigraine
Migraine
 
Migraine case presentation
Migraine case presentationMigraine case presentation
Migraine case presentation
 
Migraine
MigraineMigraine
Migraine
 
Migraine
MigraineMigraine
Migraine
 
Migrane ppt
Migrane pptMigrane ppt
Migrane ppt
 
Plantar fasciitis
Plantar fasciitisPlantar fasciitis
Plantar fasciitis
 

Ähnlich wie Migraine

MIGRAINE neurovision 2019.pptx
MIGRAINE neurovision 2019.pptxMIGRAINE neurovision 2019.pptx
MIGRAINE neurovision 2019.pptxBagadi Suneel
 
Headache with Special Reference to Migraine
Headache with Special Reference to MigraineHeadache with Special Reference to Migraine
Headache with Special Reference to MigraineAbinayaa Arasu
 
Neuropsychiatric aspects of headache
Neuropsychiatric aspects of headacheNeuropsychiatric aspects of headache
Neuropsychiatric aspects of headacheJITHIN T JOSEPH
 
1.Ocular headache and the causes of raised ocular pressure
1.Ocular headache and the causes of raised ocular pressure1.Ocular headache and the causes of raised ocular pressure
1.Ocular headache and the causes of raised ocular pressureBARNABASMUGABI
 
Migraine in children by Rafi
Migraine in children by RafiMigraine in children by Rafi
Migraine in children by RafiMahammad Rafi
 
Approach to headache
Approach to headacheApproach to headache
Approach to headacheOmkar Singh
 
Central Nervous System 1
Central Nervous System 1Central Nervous System 1
Central Nervous System 1beezusbiebs
 
Central Nervous System, Epilepsy, Parkinson, Alzheimer, Stroke and Migraine.
Central Nervous System, Epilepsy, Parkinson, Alzheimer, Stroke and Migraine.Central Nervous System, Epilepsy, Parkinson, Alzheimer, Stroke and Migraine.
Central Nervous System, Epilepsy, Parkinson, Alzheimer, Stroke and Migraine.Dr. Kiran Dhamak
 
Headache and associated emergencies
Headache  and associated emergenciesHeadache  and associated emergencies
Headache and associated emergenciesAhmad Shahir
 
Epilepsy, status epilepticus - General Medicine - ATOT
Epilepsy, status epilepticus - General Medicine - ATOTEpilepsy, status epilepticus - General Medicine - ATOT
Epilepsy, status epilepticus - General Medicine - ATOTDr. Salman Ansari
 
Headaches & Epilepsy, Presentation from Epilepsy Education Exchange 2014
Headaches & Epilepsy, Presentation from Epilepsy Education Exchange 2014Headaches & Epilepsy, Presentation from Epilepsy Education Exchange 2014
Headaches & Epilepsy, Presentation from Epilepsy Education Exchange 2014jgreenberger
 
migraine genetics ppt
migraine genetics pptmigraine genetics ppt
migraine genetics pptBarun Sen
 

Ähnlich wie Migraine (20)

MIGRAINE neurovision 2019.pptx
MIGRAINE neurovision 2019.pptxMIGRAINE neurovision 2019.pptx
MIGRAINE neurovision 2019.pptx
 
Headache
HeadacheHeadache
Headache
 
Migrine :pain management.
Migrine :pain management.Migrine :pain management.
Migrine :pain management.
 
Headache ; dr jayesh
Headache  ; dr jayeshHeadache  ; dr jayesh
Headache ; dr jayesh
 
Headache with Special Reference to Migraine
Headache with Special Reference to MigraineHeadache with Special Reference to Migraine
Headache with Special Reference to Migraine
 
Neuropsychiatric aspects of headache
Neuropsychiatric aspects of headacheNeuropsychiatric aspects of headache
Neuropsychiatric aspects of headache
 
1.Ocular headache and the causes of raised ocular pressure
1.Ocular headache and the causes of raised ocular pressure1.Ocular headache and the causes of raised ocular pressure
1.Ocular headache and the causes of raised ocular pressure
 
Migraine
Migraine Migraine
Migraine
 
HEADACHE.pptx
HEADACHE.pptxHEADACHE.pptx
HEADACHE.pptx
 
Migraine in children by Rafi
Migraine in children by RafiMigraine in children by Rafi
Migraine in children by Rafi
 
Headace
HeadaceHeadace
Headace
 
Approach to headache
Approach to headacheApproach to headache
Approach to headache
 
Aprroach to Headache.pptx
Aprroach  to Headache.pptxAprroach  to Headache.pptx
Aprroach to Headache.pptx
 
Central Nervous System 1
Central Nervous System 1Central Nervous System 1
Central Nervous System 1
 
Central Nervous System, Epilepsy, Parkinson, Alzheimer, Stroke and Migraine.
Central Nervous System, Epilepsy, Parkinson, Alzheimer, Stroke and Migraine.Central Nervous System, Epilepsy, Parkinson, Alzheimer, Stroke and Migraine.
Central Nervous System, Epilepsy, Parkinson, Alzheimer, Stroke and Migraine.
 
Headache and associated emergencies
Headache  and associated emergenciesHeadache  and associated emergencies
Headache and associated emergencies
 
Epilepsy, status epilepticus - General Medicine - ATOT
Epilepsy, status epilepticus - General Medicine - ATOTEpilepsy, status epilepticus - General Medicine - ATOT
Epilepsy, status epilepticus - General Medicine - ATOT
 
Headaches & Epilepsy, Presentation from Epilepsy Education Exchange 2014
Headaches & Epilepsy, Presentation from Epilepsy Education Exchange 2014Headaches & Epilepsy, Presentation from Epilepsy Education Exchange 2014
Headaches & Epilepsy, Presentation from Epilepsy Education Exchange 2014
 
migraine genetics ppt
migraine genetics pptmigraine genetics ppt
migraine genetics ppt
 
EPILEPSY
EPILEPSYEPILEPSY
EPILEPSY
 

Kürzlich hochgeladen

Hematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes FunctionsHematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes FunctionsMedicoseAcademics
 
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara RajendranMusic Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara RajendranTara Rajendran
 
Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.ANJALI
 
Apiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.pptApiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.pptkedirjemalharun
 
Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!ibtesaam huma
 
Culture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptxCulture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptxDr. Dheeraj Kumar
 
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...Wessex Health Partners
 
PULMONARY EDEMA AND ITS MANAGEMENT.pdf
PULMONARY EDEMA AND  ITS  MANAGEMENT.pdfPULMONARY EDEMA AND  ITS  MANAGEMENT.pdf
PULMONARY EDEMA AND ITS MANAGEMENT.pdfDolisha Warbi
 
Let's Talk About It: To Disclose or Not to Disclose?
Let's Talk About It: To Disclose or Not to Disclose?Let's Talk About It: To Disclose or Not to Disclose?
Let's Talk About It: To Disclose or Not to Disclose?bkling
 
History and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfHistory and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfSasikiranMarri
 
LUNG TUMORS AND ITS CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS  CLASSIFICATIONS.pdfLUNG TUMORS AND ITS  CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS CLASSIFICATIONS.pdfDolisha Warbi
 
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdfLippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdfSreeja Cherukuru
 
Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.Prerana Jadhav
 
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptxSYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptxdrashraf369
 
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...Badalona Serveis Assistencials
 
call girls in paharganj DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in paharganj DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️call girls in paharganj DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in paharganj DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️saminamagar
 
call girls in green park DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in green park  DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️call girls in green park  DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in green park DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️saminamagar
 
call girls in aerocity DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in aerocity DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️call girls in aerocity DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in aerocity DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️saminamagar
 
See the 2,456 pharmacies on the National E-Pharmacy Platform
See the 2,456 pharmacies on the National E-Pharmacy PlatformSee the 2,456 pharmacies on the National E-Pharmacy Platform
See the 2,456 pharmacies on the National E-Pharmacy PlatformKweku Zurek
 
Radiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxRadiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxDr. Dheeraj Kumar
 

Kürzlich hochgeladen (20)

Hematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes FunctionsHematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes Functions
 
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara RajendranMusic Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
 
Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.
 
Apiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.pptApiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.ppt
 
Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!
 
Culture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptxCulture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptx
 
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
 
PULMONARY EDEMA AND ITS MANAGEMENT.pdf
PULMONARY EDEMA AND  ITS  MANAGEMENT.pdfPULMONARY EDEMA AND  ITS  MANAGEMENT.pdf
PULMONARY EDEMA AND ITS MANAGEMENT.pdf
 
Let's Talk About It: To Disclose or Not to Disclose?
Let's Talk About It: To Disclose or Not to Disclose?Let's Talk About It: To Disclose or Not to Disclose?
Let's Talk About It: To Disclose or Not to Disclose?
 
History and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfHistory and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdf
 
LUNG TUMORS AND ITS CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS  CLASSIFICATIONS.pdfLUNG TUMORS AND ITS  CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS CLASSIFICATIONS.pdf
 
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdfLippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
 
Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.
 
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptxSYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
 
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
 
call girls in paharganj DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in paharganj DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️call girls in paharganj DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in paharganj DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
 
call girls in green park DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in green park  DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️call girls in green park  DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in green park DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
 
call girls in aerocity DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in aerocity DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️call girls in aerocity DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in aerocity DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
 
See the 2,456 pharmacies on the National E-Pharmacy Platform
See the 2,456 pharmacies on the National E-Pharmacy PlatformSee the 2,456 pharmacies on the National E-Pharmacy Platform
See the 2,456 pharmacies on the National E-Pharmacy Platform
 
Radiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxRadiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptx
 

Migraine

  • 1. MIGRAINE - Dr. Raajit Chanana 1
  • 2. Introduction ∗ Migraine headache is a complex recurrent headache that is one of the most common complaints in medicine. 2
  • 5. Childhood periodic syndromes that are commonly precursors of migraine 5
  • 8. Pathophysiology Vascular theory It was believed that ischemia induced by intracranial vasoconstriction is responsible for the aura of migraine and the subsequent rebound vasodilation and activation of perivascular nociceptive nerve resulted in headache. Based on 3 observations -: 1. Extracranial vessels become distended and pulsatile during an attack 2. Stimulation of an intracranial vessels in an awake person induces headache 3. Vasoconstrictors improve the headache and vaso dilators provoke an attack 8
  • 9. Patho Physiology contd… Neurovascular theory ∗ Complex series of neural and vascular events initiates migraine ∗ Migraine is primarily a neurogenic process with secondary changes in cerebral perfusion Cortical spreading depression ∗ CSD is a well defined wave of neuronal excitation in the cortical grey matter that spreads from its site of origin at the rate of 2- 6mm/min ∗ This cellular depolarization causes the primary cortical phenomenon aura phase, in turn, it activates trigeminal fibers causing headache. 9
  • 10. Patho Physiology contd… Vasoactive substances and Neurotransmitters ∗ Perivascular nerve activity results in release of substances such as substance P, neurokinin A, CGRP and NO which produce vessel dilation, protein extravasation and sterile inflammation stimulating the trigeminocervical complex. Cutaneous Allodynia ∗ Secondary pain pathways of the trigeminophthalamic system become sensitized during a migraine attack. 10
  • 11. Patho Physiology contd… Dopamine pathway ∗ Some of the symptoms associated with migraine such as nausea, vomiting, yawning, hyperactivitycan be attributed to dopaminergic stimulation. Endothelial dysfunction Serotonin and migraine ∗ Plasma extravasation mediated by vasoactive substances is blocked by ergots, sumatriptan, indomethacin, GABA agonists and benzodiazepines ∗ 5HT-1D receptors in trigeminal sensory neurons and 5HT 1B receptors are present on smooth vessels in the meningeal vessels 11
  • 12. Etiology ∗ Approx 70% of patients have a first degree relative with a history of migraine. Familial Hemiplegic Migraine ∗ Migraine with aura that is preceded or followed by hemiplegia that typically resolves ∗ FHM type 1 - Linked to mutations in the calcium channel gene – chromosome 19.May be associated with cerebellar ataxia ∗ FHM type 2 - mutation in the sodium channel gene ATP1A2 on chromosome 3 ∗ FHM type 3- mutation in a sodium channel alpha subunit coding gene 12
  • 13. Etiology contd… Migraine in inherited disorders -: 1. MELAS (mitochondrial myopathy, encephalopathy and lactic acidosis) 2. CADASIL (cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy) 3. Genetic vasculopathies like RVCL (retinal vasculopathy with cerebral leukodystrophy) etc. 13
  • 14. Epidemiology ∗ Migraine accounts for 64% of severe headaches in females and 43% of severe headaches in males. Migrain Without Aura Migraine with Aura Boys Girls Boys Girls Peaks at 5 years 12-13 years 10-11 years 14-17 years ∗ In individuals >12yr of incidence increases with age, reaching a peak at 30-40 yrs ∗ F:M = 3.5:1 at 40yrs 14
  • 15. Clinical presentation History ∗ U/L, throbbing or pulsatile localized in the frontotemporal and ocular areas but be felt anywhere around the head or neck. ∗ Pain builds over 1-2 hrs and become diffuse. ∗ Many patient prefer to lie in dark room Other symptoms ∗ Nausea, vomiting, anorexia and food intolerance occur in about 50 % of patients. Photophobia and phonophobia are commonly associated with headache. ∗ Hemiparesis, confusion, apathy 15 numbness. and
  • 16. Clinical presentation contd… Prodrome ∗ About 60% of patients report premonitory symptoms that occur hours to days before headache onset. ∗ Heightened sensitivity to light, sounds and odors. ∗ Lethargy or uncontrollable yawning. ∗ Food cravings ∗ Mental and mood changes ∗ Excessive thirst and polyuria ∗ Anorexia ∗ Constipation or diarrhea 16
  • 17. Aura ∗ It is a complex of neurologic symptoms that may precede or accompany the headache phase or may occur in isolation. ∗ Usually develops over 5-20min and lasts less than 60 minutes. ∗ Can be visual, sensory, motor or combination of these Negative symptoms -: ∗ Negative scotoma ∗ Negative visual phenomenon such as homonymous hemianopia, central scotoma, tunnel vision, altitudinal visual defects etc. 17
  • 18. Aura contd… Positive symptoms ∗ Scintillating scotoma-highly characteristic of migraine ∗ Photopsia or flashes of light ∗ Heat waves ∗ Micropsia, macropsia Paresthesia Occurring in 40%of cases constitute the next most common aura. ∗ Sensory symptoms rarely occurs in isolation and usually follows visual aura. ∗ Motor symptoms may occur in 18% of patients ∗ Speech and language disturbances have been reported in 17-20% of patients 18
  • 22. Half visual field loss 22
  • 23. Migraine triggers ∗ Stress ∗ Excessive or insufficient sleep ∗ Medications (OCP, vasodilators) ∗ Strong odors eg. perfumes, cologne etc. ∗ Hormonal changes such as pregnancy, menstruation ∗ Head trauma ∗ Weather changes ∗ Metabolic or infectious disease ∗ Physical exertion ∗ Cold stimulus eg. ice cream 23
  • 24. Migraine triggers contd… ∗ Foods containing tyramine may provoke migraine 1. Aged cheese 2. Yogurt 3. Bananas 4. Vinegar 5. Beans 6. Peanuts 24
  • 25. ∗ Family history ∗ Approx 70% of patients have a first-degree relative with a history of migraine ∗ Disability assessment ∗ Simple questionnaires like MIDAS migraine disability assessment can be used to quantify the disability and for follow up 25
  • 26. Physical Examination ∗ Thorough neurologic examination is essential, results will be normal in majority ∗ Possible findings may include ∗ Cranial/cervical muscle tenderness ∗ Horner syndrome ∗ Tachycardia/ bradycardia ∗ Conjunctival injection ∗ Hypertension/hypotension ∗ Hemisensory/ hemiparetic neurological deficits ( complicated migraine) 26
  • 27. Physical Examination contd… ∗ Findings that suggest a headache diagnosis other than migraine ∗ Dim scotoma lasting a few seconds to several minutes ie amaurosis ∗ Temporal artery tenderness ∗ Meningisnus ∗ Mental status changes ∗ Focal neurologic deficit eg confusion, seizures 27
  • 28. Physical Examination contd… ∗ Focal neurologic findings that occur with headache and persist temporarily after the pain resolves suggests a migraine variant ∗ U/L paralysis or weakness-hemiplegic migraine ∗ Aphasia, dysarthria, vertigo, tinnitus, syncope, balance problems-basilar migraine ∗ Third nerve palsy with sparing of pupillary response- ophthalmoplegic migraine 28
  • 29. Diagnostic criteria ∗ Migraine without aura Diagnostic criteria:  A. At least 5 attacks fulfilling criteria B-D  B. Headache attacks lasting 4-72 hours (untreated or unsuccessfully treated)  C. Headache has at least two of the following characteristics: 1. unilateral location 2. pulsating quality 3. moderate or severe pain intensity 4. aggravation by or causing avoidance of routine physical activity (eg. walking or climbing stairs) 29
  • 30. Diagnostic criteria contd… ∗ D. During headache at least one of the following: 1. nausea and/or vomiting 2. photophobia and phonophobia ∗ E. Not attributed to another disorder 30
  • 31. Migraine with aura Diagnostic criteria -: A. At least 2 attacks fulfilling criterion B B. Migraine aura fulfilling criteria B and C for one of the subforms 1.2.1-1.2.6 as per the IHS classification C. Not attributed to another disorder 31
  • 32. Typical aura with migraine headache A. At least 2 attacks fulfilling criteria B–D B. Aura consisting of ≥1 of the following, but no motor weakness: 1. fully reversible visual symptoms including positive and/or negative features 2. fully reversible sensory symptoms including positive and/or negative features 3. fully reversible dysphasic speech disturbance 32
  • 33. Typical aura with migraine headache contd… C. At least two of the following: 1. homonymous visual symptoms and/or unilateral sensory symptoms 2. at least one aura symptom develops gradually over ≥5 min and/or different aura symptoms occur in succession over ≥5 min 3. each symptom lasts ≥5 and ≤60 min D. Headache fulfilling criteria B-D for 1.1 Migraine without aura begins during the aura or follows aura within 60 min E. Not attributed to another disorder 33
  • 34. Complications of migraine ∗ Chronic migraine Migraine headache that occurs more than 15 days a month for greater than 3 months ∗ Status migrainosus Migraine attacks persists for >72 hours. ∗ Persistent aura ( 30-60 min ) without infarction ∗ Migrainous infarction ∗ Migraine triggered seizures 34
  • 35. Work up ∗ Migraine is a clinical diagnosis. ∗ Diagnostic investigations are performed due to following reasons ∗ Exclude structural, metabolic and causes of heada ∗ Rule out comorbid disease that could complicate headache and its treatment 35
  • 36. ∗ Neuroimaging is usually not necessary except ∗ Onset of migraine after 5o years of age ∗ change in the pattern of previous migraine ∗ First or worst severe headache ∗ New onset of headache in a patient with cancer or HIV patient ∗ Headache with an abnormal neurologic examination ∗ Headache with fever ∗ Migraine and epilepsy ∗ New daily persistent headache ∗ Escalation of headache frequency/intensity in the absence of medication overuse headache ∗ Posteriorly located headaches in children 36
  • 37. ∗ Visual field testing should be performed in patients with persistent visual phenomenon ∗ Indications for lumber puncture include -: 1. First or worst headache of a patients life 2. Severe, rapid onset, recurrent headaches 3. Progressive headaches 4. Atypical chronic intractable headaches 37
  • 39. General principles of management ∗ Establish a diagnosis. ∗ Educate migraine sufferers about their condition and its treatment. ∗ Encouraging patients to track their own progress through the use of diary cards, flow charts, headache calendars and frequency and severity of attacks, the presence and degree of temporary disability, and associated symptoms such as nausea and vomiting. ∗ Create a formal management plan and individualize management. Consider comorbidity/coexisting conditions (such as heart disease, pregnancy, and uncontrolled hypertension). 39
  • 40. General principles of management contd.. ∗ Encourage the patient to identify and avoid triggers. ∗ Guard against medication-overuse headache (“rebound headache” or “drug-induced headache”). Frequent use of acute medications (ergotamine [not DHE], opiates, triptans, simple analgesics, and mixed analgesics) is generally thought to cause medication-overuse headache. ∗ Use migraine-specific agents (triptans dihydroergotamine [DHE]) in patients with moderate or severe migraine or whose mild-to- moderate headaches respond poorly to nonsteroidal anti- inflammatory drugs (NSAIDs) or combinations such as aspirin plus acetaminophen plus caffeine 40
  • 41. Acute Treatment Goals of acute migraine treatment are as follows: ∗ Treat attacks rapidly and consistently without recurrence. ∗ Restore the patient’s ability to function. ∗ Minimize the use of back-up and rescue medications. (A rescue medication is used at home when other treatments fail and permits the patient to achieve relief without the discomfort and expense of a visit to the physician’s office or emergency department.) ∗ Be cost-effective for overall management. ∗ Have minimal or no adverse events 41
  • 42. Specific medications Triptan (serotonin 1B/1Dreceptor agonists) ∗ Effective and safe ∗ acute management ∗ Appropriate initial choice in patients with moderate to severe migraine ∗ Routes-oral, subcutaneous and nasal ∗ Drugs – sumatriptan-50-100mg tablet at onset , may repeat after 2hour (max 200mg/d) ∗ Rizatriptan –most efficacious, early onset of action, 5-10 mg tablet at onset may repeat after 2hr max 30mg/d) ∗ Naratriptan, almotriptan,frovatriptan, zolmitriptan 42
  • 43. Specific medications contd… ∗ Triptans should not be used more than 3 days weekly to avoid transformed migraine and medication overuse headache ∗ Caution-avoid in patients of CAD ∗ Adverse effects ∗ Paresthesia, jaw or neck tightness, warm/cold sensation etc. 43
  • 44. Specific medications contd… ∗ Ergot alkaloids and derivatives-nonselective 5-HT1 agonists) ∗ Ergotamine PO/PR (and caffeine combination) may be considered in the treatment of selected patients with moderate to severe migraine. ∗ Dose 2mg PO, f/b 1-2mg every 30 min until attack is aborted, no more than 6mg/day ∗ Adverse effects-vasospasm, angina, tachycardia, numbness of extremities, rebound headache, ergotism, gangrene etc 44
  • 45. Specific medications contd… ∗ Dihydroergotamine- alpha adrenergic blocking agent with a direct stimulating effect on smooth muscle of peripheral and cranial blood vessels. It is a non selective 5-HT1 agonist ∗ Route- iv or nasal ∗ Dose- 1mg iv/im repeated 1 hrly , no more than 3 mg for im and 2mg for iv ∗ Nasal-1 spray 0.5mg in each nostril not more than 6 sprays/24hr ∗ DHE nasal spray is safe and effective for the treatment of acute migraine attacks and should be considered for use in patients with moderate to severe migraine ∗ DHE IV plus antiemetics IV is an appropriate treatment choice for patients with severe migraine 45
  • 46. Non specific medications Antiemetics -: ∗Oral antiemetics are an adjunct to treat nausea associated with migraine . ∗Metoclopramide IM/IV is an adjunct to control nausea and may be considered as IV monotherapy for migraine pain relief ∗Prochlorperazine IV, IM, and PR may be a therapeutic choice for migraine in the appropriate setting ∗Chlorpromazine IV ∗ Serotonin receptor (5-HT3) antagonists may be considered as adjunct therapy to control nausea in selected patients with migraine attacks 46
  • 47. Non specific medications contd… ∗ NSAIDs, nonopiate analgesics, and combination analgesics. ∗ Acetaminophen, alone, is not recommended for migraine . ∗ NSAIDs (oral) and combination analgesics containing caffeine are a reasonable first-line treatment choice for mild to moderate migraine attacks or severe attacks that have been responsive in the past to similar NSAIDs or nonopiate analgesics 47
  • 48. Non specific medications contd… ∗ Opiate analgesics. ∗ Butorphanol nasal spray is a treatment option for some patients with migraine (Grade A). Butorphanol may be considered when other medications cannot be used or as a rescue medication when significant sedation would not jeopardize the patient ∗ Other medications. ∗ Isometheptene and isometheptene combination agents may be a reasonable choice for patients with mild-to-moderate headache . ∗ Corticosteroids (dexamethasone or hydrocortisone) are a treatment choice for rescue therapy for patients with status migrainosus . 48
  • 49. Preventive treatment May be considered when -: ∗ Frequency of migraine is >2/months ∗ Duration of individual attack is longer than 24hrs ∗ Headache causes major disruption in patients lifestyle ∗ Abortive therapy fails or is overused ∗ Symptomatic medications are ineffective ∗ Use of abortive medications more than twice a week ∗ Migraine variants such as hemiplegic migraine 49
  • 50. ∗ The goals of migraine preventive therapy are to 1) reduce attack frequency, severity, and duration 2)improve responsiveness to treatment of acute attacks 3)improve function and reduce disability 50
  • 51. Pharmacotherapy 5 principal classes of drugs are used -: ∗ Antiepileptics ∗ Antidepressants ∗ Antihypertenseives ∗ Serotonin antagonists ∗ NSAIDS 51
  • 52. ANTIEPILEPTICS ∗ Well tolerated ∗ Valproic acid is useful as afirst line agent.400-600 mg BD ∗ Carbamazepine ∗ Gabapentin ∗ topiramate 52
  • 53. ∗ ANTIDEPRESSANTS ∗ Tricyclic antidepressants ∗ Amitriptyline- 10-75mg at night ∗ Nortriptyline Selective serotonin reuptake inhibitors ∗ Fluoxetine ∗ Other antidepressants ∗ Bupropion, mirtazepine, trazodone, venlafaxine 53
  • 54. ∗ ANTIHYPERTENSIVES ∗ Beta-blockers ∗ Propranolol -40-120mg BD ∗ Timolol ∗ Calcium channel blockers ∗ Diltiazem ∗ Nimodipine ∗ Verapamil 54
  • 55. SEROTONIN ANTAGONISTS Methysergide-1-4mg OD ∗ Flunarizine5-15mg OD ∗ NSAIDS ∗ Aspirin ∗ Mefenamic acid ∗ Ibuprofen ∗ Naproxen/naproxen sodium ∗ Other ∗ Magnesium ∗ Vitamin B2 55
  • 56. ∗ Special considerations ∗ Direct special attention to women who are pregnant or want to become pregnant. Preventive medications may have teratogenic effects. ∗ Take coexisting conditions into account. Some (comorbid/coexisting) conditions are more common in persons with migraine. ∗ Eg-beta blocker are preferred in young anxious patients, hypertensive patients, history of angina ∗ TCA’s are preferred in patients of depression, underweight ∗ Valproic acid is preferred in patients of epilepsy and mania 56
  • 57. Non-pharmacological treatment ∗ Biofeedback ∗ Cognitive-behaviour therapy ∗ Relaxation therapy ∗ AVOIDANCE OF MIGRAINE TRIGGERS ∗ Complimentary and alternative therapy ∗ Body work eg. massage ∗ Creative arts eg. dance, music ∗ Yoga ∗ Acupuncture and acupressure 57

Hinweis der Redaktion

  1. fdsfdfg